Publications
Here you will find a comprehensive collection of all publications of the Leibniz Institute of Virology up to the year 1974. Use the filter options on the left to search specifically by year, author, research unit and journal. The search field also allows you to explore specific topics.
1974 - 2025
Displaying results 1 to 10 of 12.
Search narrowed by:
Publication
| 2017
Brief Report: Increased Frequency of CD39+ CD56bright Natural Killer Cells in HIV-1 Infection Correlates With Immune Activation and Disease Progression.
- Dierks P, Wroblewski R, Eberhard JM, Martrus G, Degen O, Hertling S, Schmiedel S, Lunemann S, Hüfner A, Lohse AW, Altfeld M, van Lunzen J, Schulze Zur Wiesch J
-
J Acquir Immune Defic Syndr,
Publication
| 2016
Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity.
- Karpinski J, Hauber I, Chemnitz J, Schäfer C, Paszkowski-Rogacz M, Chakraborty D, Beschorner N, Hofmann-Sieber H, Lange UC, Grundhoff A, Hackmann K, Schrock E, Abi-Ghanem J, Pisabarro MT, Surendranath V, Schambach A, Lindner C, van Lunzen J, Hauber J, Buchholz F
-
Nat Biotechnol,
Publication
| 2016
Parallel assessment of Th17 cell frequencies by surface marker co-expression versus ex vivo IL-17 production in HIV-1 infection.
- Dunay GA, Tóth I, Eberhard JM, Degen O, Tolosa E, van Lunzen J, Hauber J, Schulze Zur Wiesch J
-
Cytometry B Clin Cytom,
Publication
| 2016
Linker-Region Modified Derivatives of the Deoxyhypusine Synthase Inhibitor CNI-1493 Suppress HIV-1 Replication.
- Schröder M, Kolodzik A, Windshügel B, Krepstakies M, Priyadarshini P, Hartjen P, van Lunzen J, Rarey M, Hauber J, Meier C
-
Arch Pharm (Weinheim),
Publication
| 2015
Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study.
- Geissler R, Hauber I, Funk N, Richter A, Behrens M, Renner I, Chemnitz J, Hofmann-Sieber H, Baum H, van Lunzen J, Boch J, Hauber J, Behrens SE
-
Virology,
Publication
| 2015
Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1.
- Ruffin N, Brezar V, Ayinde D, Lefebvre C, Schulze Zur Wiesch J, van Lunzen J, Bockhorn M, Schwartz O, Hocini H, Lelievre JD, Banchereau J, Levy Y, Seddiki N
-
AIDS,
Publication
| 2014
CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression.
- Eberhard JM, Hartjen P, Kummer S, Schmidt RE, Bockhorn M, Lehmann C, Balagopal A, Hauber J, van Lunzen J, Schulze zur Wiesch J
-
PLoS One,
Publication
| 2014
Reduced expression of Blimp-1 in memory B cells in patients with HIV-1 infection suggests distinct roles of this molecule for B and T cell regulation.
- Beisel C, Toth I, van Lunzen J, Schulze Zur Wiesch J
-
AIDS,
Publication
| 2014
Sex differences in infectious diseases-common but neglected.
- van Lunzen J, Altfeld M
-
J Infect Dis,
Publication
| 2012
Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG.
- Hartjen P, Frerk S, Hauber I, Matzat V, Thomssen A, Holstermann B, Hohenberg H, Schulze W, Schulze Zur Wiesch J, van Lunzen J
-
AIDS Res Ther,
